We are live on
!
Find out more
Parnassus Investments Portfolio holdings
AUM
$37.4B
1-Year Est. Return
35.42%
This Fund
S&P 500
This Quarter
Est. Return
-6.06%
1 Year Est. Return
+35.42%
3 Year Est. Return
+106.24%
5 Year Est. Return
+128.96%
10 Year Est. Return
+492.3%
AUM
$38.4B
AUM Growth
-$3.45B
(-8.2%)
Cap. Flow
-$465M
Cap. Flow
% of AUM
-1.21%
Top 10 Holdings %
Top 10 Hldgs %
32.82%
Holding
135
New
5
Increased
54
Reduced
32
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$874M |
| 2 |
Abbott
ABT
|
+$530M |
| 3 |
Adobe
ADBE
|
+$227M |
| 4 |
Intercontinental Exchange
ICE
|
+$215M |
| 5 |
Ball Corp
BALL
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$585M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$515M |
| 3 |
Nike
NKE
|
+$280M |
| 4 |
American Tower
AMT
|
+$263M |
| 5 |
Home Depot
HD
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.72% |
| 2 | Financials | 16.96% |
| 3 | Industrials | 15.01% |
| 4 | Healthcare | 14.84% |
| 5 | Communication Services | 10.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Alnylam Pharmaceuticals
ALNY
$31.4B
| $5.2M | 0.01% |
25,970
-32,068
| -55% | -$6.12M |
|
127
Teradyne
TER
$56.9B
| $3.74M | 0.01% |
49,728
| – | – |
|
128
Angi Inc
ANGI
$199M
| – | – |
-229,374
| Closed | -$10.5M |
|
|
129
Boston Scientific
BSX
$67.9B
| – | – |
-15,691,959
| Closed | -$585M |
|
130
Intel
INTC
$484B
| – | – |
-2,803,269
| Closed | -$105M |
|
131
lululemon athletica
LULU
$13.5B
| – | – |
-54,564
| Closed | -$14.9M |
|
|
132
Nike
NKE
$58.2B
| – | – |
-2,743,938
| Closed | -$280M |
|
133
Novartis
NVS
$292B
| – | – |
-1,242,128
| Closed | -$105M |
|
134
PepsiCo
PEP
$192B
| – | – |
-915,459
| Closed | -$153M |
|
Similar funds
ECSS
PIF
TWC
Parnassus Investments's Q3 2022 Portfolio in Review
As of Q3 2022, Parnassus Investments held 135 positions worth $38.4B, down 8.2% from $41.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Parnassus Investments's Q3 2022 filing shows 5 new, 54 increased, 32 reduced and 7 closed positions. Its largest new stake was Oracle: 11,936,640 shares worth $729M. The largest sale was Boston Scientific, an estimated $585M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Parnassus Investments's largest Q3 2022 buy was Oracle: 11,936,640 shares worth $729M.
- Parnassus Investments added most to Adobe in Q3 2022, an estimated $227M increase.
- Parnassus Investments's biggest Q3 2022 reduction was Alexandria Real Estate Equities, cutting an estimated $515M.
- Parnassus Investments fully exited Boston Scientific in Q3 2022, selling an estimated $585M.
- Parnassus Investments's ten largest holdings make up 33% of its $38.4B portfolio in Q3 2022.
- Parnassus Investments opened 5 new positions and closed 7 in Q3 2022.
- Parnassus Investments's portfolio value fell 8.2% quarter-over-quarter to $38.4B.
Based on Parnassus Investments's 13F filing for Q3 2022, filed 14 Nov 2022.